GH Research PLC

Research GH Research PLC (GHRS) on Bullrun: market cap USD 1.95B. Explore financials, valuation history, model signals, and stock context.

Key Metrics

• TickerGHRS
• ExchangeNASDAQ
• CountryIreland
• SectorHealthcare
• IndustryBiotechnology
• CurrencyUSD
• Market capUSD 1.95B
• Financial periodQ1 2026
• Net income-USD 18.97M
• Free cash flow-USD 10.73M

Valuation Snapshot

latest market cap is USD 1.95B.

About GH Research PLC

GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States. The company's lead product candidate is GH001, an inhalable mebufotenin product candidate that is in Phase 2b clinical trial for treating patients with treatment-resistant depression and in Phase 2a clinical trials for treating bipolar II disorder and postpartum depression.

Frequently asked questions

What is GH Research PLC's market cap?

GH Research PLC's market capitalization is USD 1.95B.

What does GH Research PLC do?

GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States.